A total of $150K was awarded to six pediatric cardiovascular innovations during the medical device pitch competition at the 6th Annual Pediatric Device Innovation Symposium hosted by Children's National Health System. Award winners with Children’s National Vice President Kolaleh Eskandanian (far left) and CEO Kurt Newman, MD, (far right) include: Ken Nelson, Bardy Diagnostics; Henri Justino, MD, PolyVascular Corp.; Corin Williams, Draper; Doug Vincent, VentriFlo; Joshua Woolley, NuPulseCV; and Kurt Newman, MD, Children’s National Health System. Peca Labs, not pictured, was also an award recipient. Photo credit: Paul Loftland Photograph
Six companies presenting innovative medical devices that address significant unmet needs in pediatric healthcare were awarded a total of $150,000 in grants in Philadelphia, Pennsylvania at the Sixth Annual Pediatric Device Innovation Symposium organized by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Health System.
The “Make Your Medical Device Pitch for Kids!” competition this year focused on pediatric cardiovascular devices, an area where new devices can make a life-changing difference, especially for younger children. The Centers for Disease Control and Prevention estimate that 40,000 children are born annually in the U.S. with a congenital heart defect (CHD) and approximately 1 million U.S. children currently live with a CHD.
The pitch competition was originally slated to award $100,000 in grants; however, because of the judges’ response to the quality and potential of the technologies presented, Children’s National expanded the award grants to $150,000 to include six awardees.
Each of the award-winning companies received a $25,000 grant to help bring their pediatric medical device to market faster. Along with the funds, the awardees will receive advisory services from the Sheikh Zayed Institute’s innovation resource network. The winners were selected from a field of eleven finalists, with a total of 45 device submissions received from national and international innovators. The awards were announced at the symposium’s closing reception hosted by Children’s Hospital of Philadelphia.
This year’s pediatric device competition award recipients are:
Bardy Diagnostics, Seattle, Washington – a single patient use, continuous recording ambulatory ECG monitor that records for up to 7 days and is useable for all pediatric patients
Design Mentor Inc., Pelham, New Hampshire – VentriFlo, an extracorporeal blood pump for short-term cardiopulmonary support of pediatric open-heart surgery patients requiring full or partial cardiopulmonary bypass
Draper, Cambridge, Massachusetts – A pediatric valve designed for children, birth to age 6, that passively expands to a two-fold change in valve diameter to accommodate child growth
NuPulseCV, Raleigh, North Carolina – a minimally invasive, long-term mechanical circulatory support device for pediatric patients with cardiac dysfunction
PECA Labs, Pittsburgh, Pennsylvania – A novel expandable cardiovascular conduit that uses a minimally-invasive balloon catheter to allow for pediatric growth to reduce surgeries
PolyVascular Corp., Houston, Texas – A minimally-invasive pediatric pulmonary valve replacement approach for young children with congenital heart disease
“We are honored to recognize these outstanding innovations and we already envision the ways they can advance care for children,” says Kolaleh Eskandanian, Ph.D., vice president and chief innovation officer at Children’s National and principal investigator of the National Capital Consortium for Pediatric Device Innovation (NCC-PDI). “We are delighted to welcome these new innovative companies to our family of pediatric device startups and entrepreneurs. Together we can address critical patient needs and bring important new pediatric devices to market.”
Eskandanian says that, in addition to the financial support and consultation services through Children’s National, the awardees can leverage the validation received through this highly competitive process to raise the additional capital needed for commercialization.
The eleven finalists each made 5-minute presentations to the symposium audience and then responded to judges’ questions. Finalists also included CardioSounds, Circadiance, EspeRare Foundation, Flow Forward Medical Inc., and PyrAmes Inc.
The following experts served on the distinguished panel of judges:
- Susan Alpert, M.D., of SFA Consulting, a former director of the Food and Drug Administration (FDA) Office of Device Evaluation and former senior vice president and chief regulatory officer of Medtronic
- Vivian Emmely de Ruijter, MD, a pediatric surgery fellow at Stanford University Pediatric Health Technology Incubator
- James R. Love, partner, the law firm of Oblon
- Matt Maltese, PhD, director of Biomechanics Research for the Department of Anesthesiology & Critical Care Medicine at Children's Hospital of Philadelphia
- John Parker, managing director at Springhood Ventures L.L.C.
- Jacqueline Phillips, M.D., senior director, Pediatric Product Development, Johnson & Johnson
- Kyp Sirinakis, managing partner, Epidarex Capital
- Eric Stone, CEO and co-founder, Velano Vascular Inc.
- Kathryn Zavala, PhD, vice president of operations and business development, MedTech Innovator
The pitch competition is one of the highlights of the annual one-day symposium organized by Children’s National to bring together medical device innovators, investors, researchers, clinicians, and policy makers to advance pediatric healthcare and address the unmet surgical and medical device needs of children. The nation’s leading pediatric device symposium is a joint effort with The MedTech Conference powered by AdvaMed, the premier gathering of medtech professionals in North America.
Keynote speakers at the symposium, which was themed “Using Real World Evidence to Drive Pediatric Innovation,” included Hemant Virkar, president and CEO of Digital Infuzion Inc; Tonya Kinlow, vice president of community engagement, advocacy & government affairs at Children’s National; Susan Sweat, senior vice president, Cornerstone Government Affairs; and Vasum Peiris, M.D., chief medical officer, Pediatrics and Special Populations, FDA, whose remarks were part of a live podcast “BioTalk with Rich Bendis,” hosted by Richard Bendis, president and CEO of BioHealth Innovation Inc.